Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hoadley

Showing results (141-150 of 191) with videos related to

Pageof 20
Sort By:
Nature Communications|November 4, 2023
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trialsMattia Rediti, Aranzazu Fernandez-Martinez, David Venet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancerLisa A Carey, Hope S Rugo, P Kelly Marcom, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder CancerJeffrey S Damrauer, Kyle R Roell, Markia A Smith, et al.
Cell|April 7, 2018
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerKatherine A Hoadley, Christina Yau, Toshinori Hinoue, et al.
Cancer Discovery|November 28, 2019
Gain-of-Function <i>RHOA</i> Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric CancerHaisheng Zhang, Antje Schaefer, Yichen Wang, et al.
Plos One|March 16, 2018
Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer GenesVonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Plos One|March 2, 2013
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genesVonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Pageof 20

Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Nature Communications|November 4, 2023
Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trialsMattia Rediti, Aranzazu Fernandez-Martinez, David Venet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancerLisa A Carey, Hope S Rugo, P Kelly Marcom, et al.
The Journal of Clinical Investigation|February 27, 2018
Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancerMarni B Siegel, Xiaping He, Katherine A Hoadley, et al.
NPJ Breast Cancer|July 20, 2017
DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome AtlasMelissa A Troester, Katherine A Hoadley, Monica D'Arcy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder CancerJeffrey S Damrauer, Kyle R Roell, Markia A Smith, et al.
Cell|April 7, 2018
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of CancerKatherine A Hoadley, Christina Yau, Toshinori Hinoue, et al.
Cancer Discovery|November 28, 2019
Gain-of-Function <i>RHOA</i> Mutations Promote Focal Adhesion Kinase Activation and Dependency in Diffuse Gastric CancerHaisheng Zhang, Antje Schaefer, Yichen Wang, et al.
Plos One|March 16, 2018
Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer GenesVonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
Plos One|March 2, 2013
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genesVonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Pageof 20